US to resume use of J&J COVID-19 vaccine immediately - FDA, CDC
"The benefits do clearly outweigh the risk from a population and individual perspective."
A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021. (photo credit: REUTERS/DADO RUVIC/ILLUSTRATION/FILE PHOTO)
